InQu is a platform technology for tissue regeneration and is used primarily as an osteobiologic product in spinal fusion applications and is manufactured and marketed in a variety of forms — granules, paste, putty and strip — to meet surgeons’ needs for a variety of surgical applications. InQu has received 510(k) clearances as a bone graft extender and substitute, and since its launch in 2008, it has been used in over 17,000 orthopedic and spinal procedures to date.
Related Articles on Orthopedic Devices:
Hospital for Special Surgery’s Susanne Maher Gets $250k for Osteoarthritis Implant Development
Nanovis Announces Allowance of Key Nanosurface Patents in Canada
SANUWAVE Technology Shown to Proliferate Stem Cells and Form Bone
